Trial Profile
A Study to Investigate the Effects of T4P1001 Treatment in Patients With Peripheral Neuropathic Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs T4P 1001 (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Tools4Patient
- 16 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Dec 2014 New trial record